Long-Term Follow-up Safety of Clonidine Micropellets



Status:Enrolling by invitation
Conditions:Neurology
Therapuetic Areas:Neurology
Healthy:No
Age Range:18 - 70
Updated:1/17/2019
Start Date:November 15, 2018
End Date:May 2019

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

A Multicenter, Randomized, Follow-up Study to Evaluate the Long-Term Safety of Clonidine Micropellets for the Treatment of Pain Associated With Lumbosacral Radiculopathy in Adults

Long-term follow-up study to evaluate the safety of clonidine micropellets up to 12 months
post injection.


Inclusion Criteria:

- Subject who have successfully completed all STX-015-18-01 study related activities,
are reconfirmed to be eligible and have signed informed consent to participate.

Exclusion Criteria:

- Subjects who, in the opinion of the investigator, have demonstrated significant
non-compliance with STX-015-18-01 study procedures.

- Subjects who were unblinded to their treatment in STX-015-18-01 study.
We found this trial at
7
sites
Sollis Clinical Study Site 35
Fort Lauderdale, Florida 33316
?
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Sollis Clinical Study Site 12
Bloomington, Illinois 61704
?
mi
from
Bloomington, IL
Click here to add this to my saved trials
Sollis Clinical Study Site 13
Chicago, Illinois 60657
?
mi
from
Chicago, IL
Click here to add this to my saved trials
Sollis Clinical Study Site 23
Morgantown, West Virginia 26505
?
mi
from
Morgantown, WV
Click here to add this to my saved trials
Sollis Clinical Study Site 17
Shrewsbury, New Jersey 60657
?
mi
from
Shrewsbury, NJ
Click here to add this to my saved trials
Sollis Clinical Study Site 30
Washington, District of Columbia 22205
?
mi
from
Washington,
Click here to add this to my saved trials
Sollis Clinical Study Site 18
Winston-Salem, North Carolina 27103
?
mi
from
Winston-Salem, NC
Click here to add this to my saved trials